<DOC>
	<DOCNO>NCT02889653</DOCNO>
	<brief_summary>The purpose study determine incidence severity bleed complication patient cerebrovascular cardiovascular disease treat oral antithrombotic therapy .</brief_summary>
	<brief_title>The Bleeding With Antithrombotic Therapy Study 2</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<criteria>Patients cerebrovascular cardiovascular disease start continue take oral antithrombotics ( antiplatelets and/or anticoagulant ) prevent vascular event Patients able receive MRI Provision write informed consent either directly suitable surrogate MRI contraindication Any condition opinion responsible physician investigator render patient unsuitable study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>